29 Sep 2022
<中規模製薬企業の第4四半期主要データ>
#Madrigal/#Resmetirom、#Arrowhead/#Fazirsiran、#Ascendis/#TransConCNP の重要なデータ公開が予定され、#Biogen/#Eisai の #lecanemab の詳細データも11月のCTADカンファレンスで発表される予定だ。
evaluate.com/vantage/article…
#Evaluat
2
2
16 Jun 2021
#AscendisPharma currently has a product in their pipeline for #achondroplasia called, #TransConCNP. Learn more about this product from their Clinical Development team at #ARC2021 on Saturday, July 3 @ 11:30 AM EST. Register Now: bit.ly/ACHON21
2
2